Kasinger James R. Insider Trades & Stock Holdings

General Counsel and Secretary · CRISPR Therapeutics AG · Latest filing Oct 14, 2026

Kasinger James R., General Counsel and Secretary at CRISPR Therapeutics AG has 3 Form 4 trades on file since Sep 22, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($797.17K), net -$797.17K. Latest filing: disposed of 1.04K shares of $CRSP on Oct 14, 2026 at $49.26.

Trades on file

3

Open-market bought

$0

Open-market sold

$797.17K

Net open-market

-$797.17K

Latest filing

Oct 14, 2026

All insider trades by Kasinger James R.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 14, 2026	$CRSP	Sell (Open-market sale)	1.04K	$49.26	$51.23K						General Counsel and Secretary		Read
Oct 6, 2026	$CRSP	Sell (Open-market sale) 10b5-1	1.99K	$60.04	$119.48K			-7.2%			General Counsel and Secretary		—
Sep 22, 2026	$CRSP	Sell (Open-market sale) 10b5-1	10.40K	$60.24	$626.46K			-5.1%			General Counsel and Secretary		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kasinger James R. traded

• $CRSP

Frequently asked questions

Has Kasinger James R. been buying or selling stock?

Kasinger James R. has 0 open-market purchases and 3 open-market sales on file, net -$797.17K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kasinger James R.'s latest insider trade?

disposed of 1.04K shares of $CRSP on Oct 14, 2026 at $49.26.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.